A critical assessment of the value of lymph node dissection at radical prostatectomy: A population‐based study
Authors:
- 7 April 2011
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 71 (14) , 1587-1594
Abstract
OBJECTIVE: We tested relationship between pelvic lymph node dissection (PLND) status at the time of radical prostatectomy (RP) and survival in prostate cancer (PCa) patients.METHODS: Overall, 127,824 PCa patients treated with RP between 1988 and 2006 were included. Univariable and multivariable Cox regression analyses were used to evaluate the impact of PLND status (pN0 vs. pNx vs. pN1) on cancer‐specific mortality (CSM) and overall mortality (OM) rates.RESULTS: In pT2 patients, the 5‐, 10‐, and 15‐year CSM rates were: 0.4%, 1.7%, and 3.9% for pN0, 0.6%, 2.5%, and 4.7% for pNx, 2.7%, 11.9%, and 20.6% for pN1 patients (all P < 0.001). The 5‐, 10‐, and 15‐year OM rates were: 5.4%, 16.3%, and 34.5% for pN0, 6.1%, 18.2%, and 35.3% for pNx, 11.5%, 32.7%, and 53.4% for pN1 (all P < 0.001). In multivariable analyses, pNx and pN1 stage increased CSM rate, respectively by 1.3‐ and 3.8‐fold (both P < 0.001) relative to pN0. Similarly, pNx and pN1 increased OM rate respectively by 1.1‐ and 1.6‐fold (both P < 0.001) relative to pN0. In pT3 patients, pNx stage did not significantly increase CSM or OM rates relative to pN0 (both P > 0.05).CONCLUSIONS: Patients with localized PCa treated with RP without a PLND (pNx) have less favorable survival rate than their counterparts that do not harbor lymph node invasion at PLND. However, the difference is modest (0.8% at 10 years). In consequence, the related costs and benefits of this procedure should be weighted carefully. In addition, the survival benefit of PLND was not observed in locally advanced PCa patients. Prostate 71:1587–1594, 2011.Keywords
This publication has 15 references indexed in Scilit:
- A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial CarcinomaUrology, 2010
- Role of Androgen Deprivation Therapy for Node-Positive Prostate CancerJournal of Clinical Oncology, 2009
- Prognostic Value of Lymph Node Dissection in Patients with Muscle-Invasive Transitional Cell Carcinoma of the Upper Urinary TractEuropean Urology, 2008
- EAU Guidelines on Prostate CancerEuropean Urology, 2008
- Limited Pelvic Lymph Node Dissection Does Not Improve Biochemical Relapse-Free Survival at 10 Years After Radical Prostatectomy in Patients with Low-Risk Prostate CancerUrology, 2008
- Limited Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy Does Not Affect 5-Year Failure Rates for Low, Intermediate and High Risk Prostate Cancer: Results From CaPSURE™Journal of Urology, 2007
- Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancerUrology, 2006
- Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomyThe Lancet Oncology, 2006
- The Association Between Total and Positive Lymph Node Counts, and Disease Progression in Clinically Localized Prostate CancerJournal of Urology, 2006
- THE EXTENT OF LYMPHADENECTOMY FOR pTXNO PROSTATE CANCER DOES NOT AFFECT PROSTATE CANCER OUTCOME IN THE PROSTATE SPECIFIC ANTIGEN ERAJournal of Urology, 2005